Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -28.88% of over the last 5 years
The company has declared negative results for the last 11 consecutive quarters
With ROCE of 1.8, it has a Expensive valuation with a 1.1 Enterprise value to Capital Employed
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 496 Cr (Micro Cap)
NA (Loss Making)
37
0.34%
0.29
0.82%
1.33
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 315 as Sell-Off Deepens
A sharp decline in Chemfab Alkalis Ltd has pushed the stock to a fresh 52-week low of Rs 315 on 27 Mar 2026, marking a significant 65% drop from its 52-week high of Rs 900. This steep fall comes amid persistent financial headwinds and a broader market downturn, with the stock underperforming its sector and the benchmark indices.
Read full news article
Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 330.8 as Sell-Off Deepens
For the third consecutive session, Chemfab Alkalis Ltd has declined sharply, hitting a fresh 52-week low of Rs 330.8 on 23 Mar 2026. This drop extends the stock’s year-long slide, which now stands at a steep -55.21%, far outpacing the broader market’s modest -5.47% loss over the same period.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Closure of Trading Window
25-Mar-2026 | Source : BSESubmission of Letter for intimating the closure of trading window period w.e.f. 1st April 2026 till the expiry of 48 hours after the announcement of the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2026.
Announcement under Regulation 30 (LODR)-Credit Rating
14-Mar-2026 | Source : BSESubmission of Credit Rating Letter issued by India Ratings and Research (Ind-Ra) in respect of the Companys banking facilities.
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Jan-2026 | Source : BSESubmission of newspaper clippings on publication of unaudited financial results for the quarter and nine months ended 31st December 2025
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.08%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.56%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






